IBCSG – International Breast Cancer Study Group IBCSG-Trial 11-93 Design: N+, ER+ or PgR+, Premenopausal Breast Cancer

Publisher： Karger

E-ISSN： 2296-5262|21|3|266-267

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.21, Iss.3, 1998-07, pp. : 266-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Hereditary Premenopausal Breast Cancer

By  

Oncology Research and Treatment, Vol. 25, Iss. 1, 2002-03 ,pp. : 24-27

Karger

Access to resources Recommend Favorite

Adjuvant Endocrine Treatment in Premenopausal Early Breast Cancer

By  

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 9-13

Karger

Access to resources Recommend Favorite

Breast Cancer Risks in Premenopausal Women: A Review

By  

Current Women's Health Reviews, Vol. 1, Iss. 3, 2005-11 ,pp. : 261-271

Bentham Science Publishers

Access to resources Recommend Favorite

Phase II Trial in Japan of Sequential Administration of Weekly Paclitaxel Followed by FEC as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer [KBCSG0206 Trial: Kinki Breast Cancer Study Group (KBCSG)]

By  

Oncology, Vol. 78, Iss. 5-6, 2010-07 ,pp. : 302-308

Karger

Access to resources Recommend Favorite

A Phase II Trial of Docetaxel and Carboplatin as First-Line Chemotherapy for Metastatic Breast Cancer: NCCTG Study N9932

By  

Oncology, Vol. 69, Iss. 2, 2005-09 ,pp. : 117-121

Karger

Access to resources Recommend Favorite